Barlow D. (1977). The condom and Gonorrhoea. Lancet ; (2), 811-812
2.
Bradbeer C.S., Thin R.N., Tan R. and Thirumoorthy T. (1988). Prophylaxis against infection in Singaporean women . Genito-Urin Med;64, 52-53
3.
Darrow W.W.( 1989). Condom use and use-effectiveness in high-risk population . Sex Trans Dis; 16, 157-160
4.
Department Of Health (1992). The Health of the Nation: A strategy for health in England. London: HMSO
5.
Farley T M M, Rosenberg M.J., Rowe P.J., Chem J.H. and Meirik D. (1992). Intrauterine devices and pelvic inflammatory disease : an international perspective. Lancet;339, 785-788
6.
Handsfield H.H., Jasman LL, Roberts P.L. et al (1986). Criteria for selective screening for Chlamydia trachomatis infections in women attending Family Planning Clinics. JAMA; 255, 1730-1734
7.
Humphreys J.T., Henneberry J.F., Richard R.S. and Beebe J.L. (1992). Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado Family Planning Clinics. Sex Trans Dis;19 (1), 47-52
8.
Lee N.C., Rubin G.L. and Grimes D.A. (1991). Measures of sexual behaviour and the risk of pelvic inflammatory disease. Obstet Gynaecol;77, 425-430
9.
Mant D. and Fowler G. (1990). Mass screening: Theory and ethics. BMJ;300, 916-918
10.
Quinn R.W. and O'REILLY K R (1985). Contraceptive practices of women attending the Sexually Transmitted Disease Clinic in Nashville, Tennessee. Sex Trans Dis; 12, 99-102
11.
Rosenberg M.J., Davidson A.J., Chen J.H., Judson F.N. and Douglas J.M. (1992). Barrier contraceptives and sexually transmitted diseases in women: A comparison of female-dependent methods and condoms. Am J Public Health;82, 669-674
12.
Sprague D.S., Bullough C W H, Rashid S. and Roberts S.A. (1990). Screening for and treating Chlamydia trachomatis and Neisseria Gonorrhoea before contraceptive use and subsequent pelvic inflammatory disease. Br J F Planning;16 (2), 54-58
